COP vs HAE · P/E 19, rev $58.94B vs P/E 35, rev $1.36B
ConocoPhillips (COP) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
COP currently screens at market cap $135.49B and trailing P/E 18.8. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the COP and HAE stock pages for the full models.
Not investment advice.